
N.C. lawmakers look to crack down on psychoactive hemp products
Changes may soon be coming to North Carolina's booming hemp industry, which has thrived in recent years thanks to the state's lack of restrictions, oversight and safety standards for intoxicating weed-like products.
Why it matters: North Carolina remains one of just a handful of states where marijuana — medical or not — remains illegal. At the same time, it's among the most lenient for its regulation of products extracted from hemp, some of which can provide a weed-like high.
That lack of regulation has given way to a situation in which anything goes: Dispensaries, bars, bottle shops, restaurants and even pizzerias across the state can sell an array of intoxicating products without age restrictions.
The big picture: If a hemp bill filed Tuesday becomes law, it will transform the state's hemp industry, which has largely remained unchecked since 2022.
That year, the General Assembly passed legislation bringing the state in line with federal regulations on hemp, declassifying it as a controlled substance so long as the dry-weight product contains less than 0.3% of the psychoactive component of marijuana, delta-9 THC.
Driving the news: State Sens. Todd Johnson, Danny Britt and Michael Lazzara filed a 16-page bill Tuesday that would crack down on the manufacturing, sale and distribution of hemp.
The legislation would make it illegal for stores to sell consumable hemp-derived products to anyone under 21 or for anyone under 21 to possess the products. Additionally, the products would be prohibited on school grounds.
The bill would also require licenses for hemp manufacturers, distributors and sellers, and it would mandate that manufacturers test the products for heavy metals, pesticides and other toxic substances.
What they're saying: Among the states that are considering hemp legislation, North Carolina's bill "is one of the best — if not the very best — hemp bills in the country," cannabis advocate and business law attorney Rod Kight told Axios by email.
"It supports the state's existing hemp industry while also creating appropriate guardrails to prevent minors from accessing hemp products, mandating safety standards, and requiring specific labeling and marketing information so that adults can make informed decisions about the hemp products that they choose to purchase and use."
The intrigue: House Rules Chairman Rep. John Bell, who is the president of CBD and hemp manufacturer Asterra Labs, has been involved in discussions about the legislation.
Bell attributes his involvement to the fact that he is the only person in the industry in the state legislature, however he wasn't familiar with the details of the final version of the bill, he told Axios.
Asterra has a "pharmaceutical-grade clean facility where you can eat off the floor," Bell told WUNC last year, but it's "competing in the same market space as a guy who's making it in their backyard."
The Senate's proposal this year could put those backyard manufacturer types out of business, as it would ban home-based manufacturing.
Bell argues that, though there aren't many companies in the state doing what Asterra does, the legislation won't necessarily be a slam dunk for his company: New licensing fees would cost Asterra money and require changes to how it packages its products, for example.
Still, Bell said he'll seek an advisory opinion from the State Ethics Commission, which gives advice to legislators and other public servants on issues including conflicts of interest.
Zoom in: As of now, the state has no limits on cannabinoids with psychoactive effects much like those of THC, such as delta-8 — which is often seen in products on shelves across the Triangle — THC-O, HHC, THC-A, delta-7 and delta-10.
The cannabis plant has more than 100 cannabinoids. Some of them are psychoactive, while others, like CBD, are not.
The Senate's proposal would set dosage limits for a handful of cannabinoids — delta-7, delta-8, delta-9 and delta-10 — but would not set limits on other psychoactive cannabinoids.
For edible products, like gummies, a serving could not contain more than 75mg of delta-7, delta-8, delta-9 or delta-10. Liquid products, like drinks, could not have more than 25mg per serving.
Zoom out: "North Carolina is widely perceived to be the best hemp state in the country due to its long history with hemp and also its support for the hemp industry," Kight told Axios.
"Over the years, the state's hemp-friendly laws and overall pro-hemp environment have resulted in NC being the home base for many of the world's top companies," he wrote in a blog post Tuesday after senators filed the bill.
State of play: In 2023, UNC School of Government professor Phil Dixon told WFAE the hemp market in the state was the "wild west."
Since then, the industry has only grown: Hemp-derived edibles, drinks and joints with psychoactive effects are in some of Raleigh's favorite restaurants, bottle shops and stores.
"If anything, we are more in the Wild West than we were in '23," Dixon told Axios.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Axios
an hour ago
- Axios
Ex-GOP Rep. David Jolly launches Dem campaign for Florida governor
Former Rep. David Jolly is launching a campaign for Florida governor as a Democrat, hoping to staunch the state's lurch from purple to solidly red, Axios has learned. Why it matters: The onetime Republican, who previously weighed an independent bid for the role in 2022, believes he can succeed where so many other Democrats have failed. "Different race, different cycle, different candidate," he told Axios in an interview. "This is a race with national implications, because if we win, we will have transformed national politics." "We will have stopped MAGA in Florida, and the White House now runs through Florida in 2028," he said. State of play: Jolly is the first Democrat to throw their hat into the ring, and could be the most high-profile candidate to run with Rep. Jared Moskowitz taking himself out of contention. On the Republican side, the GOP establishment and President Trump have coalesced around Rep. Byron Donalds. Still, Democrats in the state hope that another contender — particularly former Rep. Matt Gaetz — jumps in and makes it a bloody battle. What they're saying: Despite his confidence that national trends will buoy Democrats in the Sunshine State, Jolly said he's not solely relying on anti- Trump sentiment. He is targeting affordability, education and corruption as key issues of his campaign. "The race ... is not about Donald Trump," he said. "It's not even about Ron DeSantis. It's about where he's leaving the state." Jolly told Axios he wants to help build the haggard state Democratic Party. "You will see us do that almost like happened in Virginia over the last five years," he said. That's where he thinks his past Republican registration will provide an advantage. "We have to invite in independents and common sense Republicans," he said. Yes, but: This strategy has been tried before, to less-than-stellar results. Former Rep. Charlie Crist, another Republican-turned-independent-turned-Democrat, ran against DeSantis in 2022 and lost by nearly 20 percentage points. Whether Jolly can turn the tide and buck Florida's consistent rightward trend since 2016 is still an open question.


Axios
2 hours ago
- Axios
Exclusive: OatFi nabs $24M for embedded B2B credit
OatFi, a startup providing an embedded working capital financing infrastructure, has raised $24 million in Series A funding, CEO Michael Barbosa tells Axios exclusively. How it works: OatFi partners with AP, AR, and B2B payment platforms to embed financing into invoice and payment workflows. Its APIs handle underwriting, origination, and capital deployment, which allows platforms to offer net terms and early payouts within their core systems. "We're building this credit layer that supports B2B payments, because a B2B payment is inherently a credit transaction," Barbosa says. The big picture: By standardizing embedded credit as a core part of B2B transactions, OatFi hopes to unlock liquidity for platforms, buyers, and suppliers. "The problem isn't so much the movement of the money; it's the workflow that sits on top of the movement of the money," Barbosa says. State of play: Embedded credit is becoming table stakes across B2B commerce and fintech infrastructure, with platforms like Square, Stripe, and Shopify already offering working capital to merchants based on payment flows. Meanwhile, standalone fintech lenders like Pipe, Parafin, and Settle target embedded lending through platform partnerships or direct integrations. Yes, but: Instead of bolting on a merchant cash advance product using payment data, OatFi embeds a full credit infrastructure inside AP and AR workflows, underwriting each transaction and funding it from its own warehouse lines. "Many are taking this classic, generation-one MCA strategy. That's very much not what we do," Barbosa says. Case in point: OatFi powers embedded financing for procurement tools like freight-forwarding platforms like Koverly, and spend management players like Cledara. By the numbers: The NYC-based company now works with over 20 partner platforms and says it has processed more than $500 million in total payment volume since launching in mid-2022. Zoom in: White Star Capital led the Series A round, which included participation from existing investors QED, Portage, and Lorimer Ventures.
Yahoo
4 hours ago
- Yahoo
Trump orders inquiry into Biden's actions as president
Donald Trump has ordered an investigation into Joe Biden's actions during his presidency, accusing aides of a "conspiracy" to "deceive the public about Biden's mental state". In this latest move to discredit his predecessor, Trump took aim at the aides' use of an autopen - a device that replicates signatures which presidents, including Trump, have used for decades - to sign executive actions. "This conspiracy marks one of the most dangerous and concerning scandals in American history," Trump said on Wednesday. Biden slammed Trump's move as "ridiculous", saying his claims are aimed at distracting Americans as his administration works to extend tax breaks for the wealthy. Trump and his Republican allies have long questioned Biden's mental acuity and have attempted to overturn some of the presidential pardons and federal rules issued at the end of his term in office. A Republican-led panel in the House of Representatives has sought testimony from some of Biden's closest aides, including his first chief of staff, on his "mental and physical faculties" while he was leading the country. In a statement on Wednesday, Trump, 78, said the American public had been "purposefully shielded from discovering who wielded the executive power" while Biden's signature was used to endorse documents Trump described as leading to "radical policy shifts". Biden, now 82 and fighting advanced prostate cancer, has hit back at Trump. "Let me be clear: I made the decisions during my presidency. I made the decisions about the pardons, executive orders, legislation and proclamations," he said. "Any suggestion that I didn't is ridiculous and false," Biden said in a statement on Wednesday night. Scrutiny over Biden's mental and physical capacity has intensified in recent weeks as a new book accused an inner circle within the former administration of covering up his "physical deterioration" during his ill-fated re-election campaign last year. Original Sin, written by Jake Tapper of CNN and Alex Thompson of Axios, alleges Biden's condition during the campaign was said to be so poor that aides discussed giving him a wheelchair. Biden abruptly ended his re-election campaign last July shortly after weeks of pressure following his disastrous debate performance against Trump. Some Democrats, including former US House of Representatives Speaker Nancy Pelosi, have publicly blamed Biden for not exiting the race sooner, which would have given his party more time to anoint a popular replacement. Early last month, Biden gave his first interview since leaving the White House to the BBC, maintaining he "[did not] think it would have mattered" if he had left the race sooner. Shortly after, he announced that he's been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones - which has led to more accusations from the Trump White House that those closest to the former president, including his wife Jill, would have known of his condition earlier. Biden's cancer diagnosis is another formidable challenge Joe Biden on Trump: 'What president ever talks like that? That's not who we are'